Skip to content

Author

Arzu Aysan

We have 2 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Engineering 4-Vinylcatechol Biosynthesis in Escherichia coli Through Host-Enzyme Combination.

De novo biosynthesis of 4-vinylcatechol (VCAT), a valuable bio-based monomer and potent antioxidant, has emerged as a crucial objective due to its profound industrial and pharmacological significance. However, its biosynthesis is frequently hindered by limited precursor availability. In this study, we developed a highl...

E. Kaynak, Merve Seven, Hüseyin Balcı et al. · 0 citations
Open access May 2026

Discovery and functional characterization of novel programmed death-ligand 1 monoclonal antibodies

Only one monoclonal antibody was identified as a potential therapeutic drug candidate thanks to its high capacity for checkpoint blockade and affinity, as well as its unique sequence specificity, comparable to those of anti-PD-L1 antibodies currently used in clinical practice.

Nurşah Ersezen, Maide Şeker, Arzu Aysan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.